For more information on Q30 and the Q-Collar, review the information below.


Since its formation, Q30 has been focused on transforming the invention of two doctors into a safe, effective and commercially viable medical device. This effort has included engaging leading engineers and fabricators to design and produce the Q-Collar, building a robust patent portfolio, and working with world-renowned experts and independent researchers to perform more than 25 pre-clinical and clinical studies; 17 of which have resulted in published articles. This extensive research has demonstrated the product’s safety and efficacy—most athletes who wore the Q-Collar during hockey, football and soccer sports seasons had virtually no changes to the structure of their brains while most of those who did not wear the collar experienced statistically significant structural changes, as seen with advanced MRI. The results of the research were included in Q30’s De Novo application to the US FDA that was filed in March 2020 seeking approval to sell the Q-Collar as an “over-the-counter” product. Following FDA’s review of our comprehensive application, on February 26th, the Agency cleared the Q-Collar for sale to athletes in the US, confirming both it’s safety and effectiveness.


The Q-Collar was invented and developed by a team of medical experts from different specialties. An internist, an anesthesiologist, and a neurosurgeon combined their expertise to revolutionize brain protection.


  • On February 26th, 2021, Q30 received FDA clearance to market the Q-Collar in the US, validating both the Q-Collar’s safety and effectiveness.
  • The Q-Collar is the only FDA cleared sports equipment that helps protect athletes’ brains during head impacts.
  • The FDA-clearance was based on an extensive review of 10 years of research conducted independently by leading medical and research institutions across North America.
  • As reported by the FDA, advanced imaging showed no significant changes in deeper tissues of the brain (white matter regions) in 77% of the group of athletes who wore the Q- Collar, while significant changes in these regions were found in 73% of participants in the non-Collar group.


The Q-Collar helps protect the brain from repetitive, sub-concussive impacts.


  • Repetitive Head Impacts (RHI) – Repeated hits to the head, even smaller impacts called sub-concussive hits, have been shown to result in structural changes to an athlete’s brain over the course of a season. The Q-Collar helps to protect the brain from these structural changes.
  • Brain Movement = Brain Injury – The technology behind the Q-Collar was first envisioned by doctors who identified the movement of the brain inside the skull, or “slosh,” as a key cause of structural changes to the brain. By inventing a simple, yet innovative, device worn around the neck, these doctors determined they could help reduce the movement of the brain.
  • Protection From Within – The Q-Collar helps stabilize the brain by applying light pressure to the jugular veins. This pressure slightly increases blood volume inside the skull and helps reduce the brain’s movement, which is the primary cause of brain injuries. In doing so, the Q-Collar aids in the protection of the brain from effects associated with repetitive sub-concussive head impacts.

Hear first hand from Dr. Julian Bailes, Q30’s Chief Medical Advisor, discussing the science behind the Q-Collar. Watch the vidoes below:


Bruce Angus, Co-CEO

Prior to co-founding Q30 Innovations, Bruce founded and led MoGo Sport which launched the first flavored mouthguard.  The company was sold in 2015. Bruce is also the founder and Chairman of Kids U, a chain of children’s recreational facilities.  Prior to these entrepreneurial activities, Bruce spent several years with Reebok International in the US & Asia.

Tom Hoey, Co-CEO

Prior to co-founding Q30 Innovations, Tom was President of MoGo Sport, producers of the world’s first flavored mouthguard and which was sold in 2015. Tom was also the founder & President of Hoey Properties and a co-founder of H2A Sports Marketing Group. Over his 30-year career, Tom has extensive experience in product innovation, strategic partnerships, sports marketing and advertising.

Gary Greene, General Counsel

Prior to joining Q30, Gary served as Chief Administrative Officer and General Counsel of Walker Innovation, Inc., General Counsel of the Financial Accounting Foundation and as Chief Corporate Counsel of Synapse Group, Inc. (a Time Warner company).  In his 30-year career, Gary has represented clients in various regulated industries, including telecommunications, energy, consumer marketing, and manufacturing.

Peter Groome, Chief Marketing Officer

Prior to joining Q30, Peter served as the Chief Executive Officer of Fathom Communications, a marketing services agency that he co-founded in 2001 and led for 18 years in partnership with the Omnicom Group.  Before launching Fathom, Peter worked with Omnicom’s DDB Worldwide and WPP’s Ogilvy and Mather advertising agencies in a variety of senior strategy and client service roles.


Julian Bailes

M.D. Chairman, Department of Neurosurgery; Northshore University of Health System

Joseph Fisher

M.D. Professor, Faculty of Medicine, Department of Anesthesiology, University of Toronto, Co-Inventor of the Q-Collar 

Jason Cormier

M.D. Department of Neurosurgery, Lafayette Surgical Specialty Hospital; Director, Motorsports Safety Group

Wayne Olan

Director of Interventional and Endovascular Neurosurgery, The George Washington University Medical Center


Vernon Davis

Entrepreneur and Former NFL Player

Blake Geoffrion

NHL Executive and Former NHL Player

Ryan Kuehl

Sports Marketing Consultant and Former NFL Player

Emily Menges

NWSL Player, Portland Thorns

Chris O'Donnell

Former Nike Executive

Media Contact

For more information, please contact


Q30 Innovations, LLC, is dedicated to developing innovative products intended to reduce brain injury. 

© 2021 Q30 Innovations, LLC. All Rights Reserved.







Contact Us